Tuberculosis drug discovery gets smarter with AI
2 Articles
2 Articles
Tuberculosis drug discovery gets smarter with AI
When researchers screen potential tuberculosis drugs, they often end up with too many options. Some look promising but later prove to be costly dead ends. "We might get thousands of compounds from a screen and then have to decide which one are we going to work on?" said James Sacchettini, Ph.D., the Rodger J. Wolfe-Welch Foundation Chair in Science, Texas A&M AgriLife Research scientist and professor in the Texas A&M College of Agriculture and L…
When researchers select potential TB drugs, they often find themselves with too many options. Some seem promising but then turn out to be costly impasses."We could get thousands of compounds from a screen and then have to decide which one we're going to work on?" said James Sacchettini, PhD, who holds [...]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
